SLC6A3 and Alzheimer disease: Differentiated AD-MSCs had maximum percentage of cells positive for DAT (29.48 ± 0.99%) as compared to that in DP-MSCs (22.78 ± 0.90%) and BM-MSCs (16.36 ± 0.93%).